InterCure Statistics
Share Statistics
InterCure has 47.16M
shares outstanding. The number of shares has increased by 3.49%
in one year.
| Shares Outstanding | 47.16M |
| Shares Change (YoY) | 3.49% |
| Shares Change (QoQ) | 3.05% |
| Owned by Institutions (%) | 5.25% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 569 |
| FTD / Avg. Volume | 2.68% |
Short Selling Information
The latest short interest is 26.04K, so 0.06% of the outstanding
shares have been sold short.
| Short Interest | 26.04K |
| Short % of Shares Out | 0.06% |
| Short % of Float | 0.1% |
| Short Ratio (days to cover) | 1.07 |
Valuation Ratios
The PE ratio is -4.07 and the forward
PE ratio is null.
InterCure's PEG ratio is
-0.92.
| PE Ratio | -4.07 |
| Forward PE | n/a |
| PS Ratio | 1.16 |
| Forward PS | 0.1 |
| PB Ratio | 0.7 |
| P/FCF Ratio | -3.87 |
| PEG Ratio | -0.92 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for InterCure.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.73,
with a Debt / Equity ratio of 0.53.
| Current Ratio | 1.73 |
| Quick Ratio | 1.18 |
| Debt / Equity | 0.53 |
| Debt / EBITDA | -4.12 |
| Debt / FCF | -2.96 |
| Interest Coverage | -3.26 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $884,611.11 |
| Profits Per Employee | $-251,092.59 |
| Employee Count | 270 |
| Asset Turnover | 0.31 |
| Inventory Turnover | 1.66 |
Taxes
| Income Tax | -14.53M |
| Effective Tax Rate | 16.64% |
Stock Price Statistics
The stock price has increased by -51.55% in the
last 52 weeks. The beta is 1.6, so InterCure's
price volatility has been higher than the market average.
| Beta | 1.6 |
| 52-Week Price Change | -51.55% |
| 50-Day Moving Average | 1.47 |
| 200-Day Moving Average | 1.69 |
| Relative Strength Index (RSI) | 63.36 |
| Average Volume (20 Days) | 21,230 |
Income Statement
In the last 12 months, InterCure had revenue of 238.84M
and earned -67.8M
in profits. Earnings per share was -1.42.
| Revenue | 238.84M |
| Gross Profit | 30.23M |
| Operating Income | -67.21M |
| Net Income | -67.8M |
| EBITDA | -51.31M |
| EBIT | -66.68M |
| Earnings Per Share (EPS) | -1.42 |
Full Income StatementBalance Sheet
The company has 78.32M in cash and 211.4M in
debt, giving a net cash position of -133.09M.
| Cash & Cash Equivalents | 78.32M |
| Total Debt | 211.4M |
| Net Cash | -133.09M |
| Retained Earnings | -277.58M |
| Total Assets | 762.57M |
| Working Capital | 165.05M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -66.93M
and capital expenditures -4.38M, giving a free cash flow of -71.3M.
| Operating Cash Flow | -66.93M |
| Capital Expenditures | -4.38M |
| Free Cash Flow | -71.3M |
| FCF Per Share | -1.49 |
Full Cash Flow StatementMargins
Gross margin is 12.66%, with operating and profit margins of -28.14% and -28.38%.
| Gross Margin | 12.66% |
| Operating Margin | -28.14% |
| Pretax Margin | -36.56% |
| Profit Margin | -28.38% |
| EBITDA Margin | -21.48% |
| EBIT Margin | -28.14% |
| FCF Margin | -29.85% |
